Bristol-Myers Squibb to Hold Investor Webcast to Discuss ESMO Highlights

Bristol-Myers Squibb Company (NYSE: BMY) will host a webcast on Saturday, September 28, 2019 at 7:30 p.m. CEST (1:30 p.m. EDT) to discuss data presented at the European Society of Medical Oncology, in Barcelona, Spain.

Metadata
Provider: 
Business Wire, Inc.
Retrieved on: 
Friday, September 20, 2019
Information
Tags: 
FDA, Clinical trials, Biotechnology, Pharmaceutical, Health, General Health, Oncology, Squib, Life sciences, Biotechnology, Monoclonal antibodies, Articles, Bristol-Myers Squibb
Geotags: 
NEW YORK, United States
⚠ generated by AI ↴
Organisation: 
BRISTOL-MYERS SQUIBB
Summary
Key Points: 
  • Bristol-Myers Squibb Company (NYSE: BMY) will host a webcast on Saturday, September 28, 2019 at 7:30 p.m. CEST (1:30 p.m. EDT) to discuss data presented at the European Society of Medical Oncology, in Barcelona, Spain.
  • Investors and the general public are invited to listen to a live webcast at: investor.bms.com and are urged to register prior to the webcast.
  • Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
  • For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn , Twitter , YouTube and Facebook .


Bristol-Myers Squibb Company (NYSE: BMY) will host a webcast on Saturday, September 28, 2019 at 7:30 p.m. CEST (1:30 p.m. EDT) to discuss data presented at the European Society of Medical Oncology, in Barcelona, Spain. Company executives will provide an overview of data presented at the meeting, with a focus on the company’s Immuno-Oncology portfolio, and address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast at: investor.bms.com and are urged to register prior to the webcast. Materials related to the call will be available at the same website prior to the call.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

Copyright: 
Copyright Business Wire 2019